INOVIO PHARMACEUTICALS, INC. Quarterly Other Assets, Noncurrent in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Inovio Pharmaceuticals, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2010 to Q3 2024.
  • Inovio Pharmaceuticals, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $566K, a 6.43% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $566K -$38.9K -6.43% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $586K -$81K -12.1% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $605K -$47.2K -7.23% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $605K -$78.7K -11.5% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $605K -$96.7K -13.8% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $667K -$103K -13.4% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $653K -$621K -48.8% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $684K -$742K -52% Dec 31, 2022 10-K 2024-03-06
Q3 2022 $702K -$1.05M -60% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $770K -$1.06M -57.9% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $1.27M -$24.6M -95.1% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $1.43M -$24.5M -94.5% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $1.76M -$15.9M -90.1% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $1.83M -$725K -28.4% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $25.9M +$23.4M +944% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $26M +$23.3M +871% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $17.6M +$14.9M +546% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $2.56M -$297K -10.4% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $2.48M -$501K -16.8% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $2.67M +$2.03K +0.08% Dec 31, 2019 10-K 2021-03-01
Q3 2019 $2.73M +$105K +4.01% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $2.85M +$129K +4.72% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $2.98M +$533K +21.8% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $2.67M +$30.6K +1.16% Dec 31, 2018 10-K 2020-03-12
Q3 2018 $2.63M +$428K +19.5% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $2.72M +$1.05M +62.7% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $2.45M +$923K +60.6% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $2.64M +$526K +24.9% Dec 31, 2017 10-K 2019-03-12
Q3 2017 $2.2M +$715K +48.3% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $1.67M +$348K +26.2% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 $1.53M +$490K +47.4% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $2.11M +$1.44M +215% Dec 31, 2016 10-K 2018-03-14
Q3 2016 $1.48M +$884K +148% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $1.33M +$745K +128% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 $1.03M +$370K +55.6% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 $671K +$196K +41.4% Dec 31, 2015 10-K 2017-03-15
Q3 2015 $598K +$45.1K +8.17% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $581K +$87.9K +17.8% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 $665K +$104K +18.5% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $475K +$72.5K +18% Dec 31, 2014 10-K 2016-03-14
Q3 2014 $552K +$381K +223% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 $493K +$296K +150% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 $561K +$428K +320% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 $402K +$268K +200% Dec 31, 2013 10-K 2015-03-16
Q3 2013 $171K -$52.1K -23.3% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $197K -$25.9K -11.6% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 $134K -$58.4K -30.4% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 $134K -$74.1K -35.6% Dec 31, 2012 10-K 2014-03-17
Q3 2012 $223K +$14.8K +7.1% Sep 30, 2012 10-Q 2012-11-07
Q2 2012 $223K +$14.8K +7.1% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 $192K Mar 31, 2012 10-Q 2012-05-09
Q4 2011 $208K -$50.9K -19.6% Dec 31, 2011 10-K 2013-03-18
Q3 2011 $208K Sep 30, 2011 10-Q 2011-11-07
Q2 2011 $208K Jun 30, 2011 10-Q 2011-08-05
Q4 2010 $259K Dec 31, 2010 10-K 2012-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.